LEA
MRCY
LDOS

Roger A. Krone

Known title: CEOCIK: 0001013082

Roger A. Krone's purchase track record

Roger A. Krone has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/18/2023MRCY$578K-9.1%-22.4%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

UBS and Goldman Sachs Lower Lear Price Targets. UBS and Goldman Sachs both maintained Neutral ratings on Lear but lowered their price targets to $132 and $124, respectively. This follows the stock trading near its support level, with the lower targets reflecting a more conservative outlook. The company remains in a list of attractive dividend stocks, maintaining a yield of 2.29%.

this person other insiders at LEA

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 8, 2026

Mercury Systems Launches RES One Edge Server Platform. Mercury Systems introduced RES One, a rugged edge server engineered for rapid deployment and lifecycle management. This platform expands its product line and supports national security spending. The launch positions the company within the growing defense technology market. It may influence investor perception of Mercury's growth potential.

this person other insiders at MRCY

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Leidos wins new defense and health contracts. Leidos Holdings recently secured new contracts for logistics support in the UK and health research for the U.S. Navy. These wins highlight the company's ongoing role in defense and health services. The stock is currently trading well below the average analyst target price, suggesting potential value for some investors.

this person other insiders at LDOS

Transaction History

LEA▲ Buy$0
LEA▲ Buy$0
LEA▲ Buy$0
MRCY▲ Buy$0
MRCY▲ Buy$0
MRCY▲ Buy$578K
MRCY▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$185K
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$131K
LDOS▼ Sell$207K
LDOS▲ Buy$0
LDOS▼ Sell$162K
LDOS▼ Sell$15K
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$1.5M
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$4.0M
LDOS▲ Buy$2.7M
LDOS▼ Sell$1.4M
LDOS▼ Sell$54K
LDOS▲ Buy$2.7M
LDOS▼ Sell$4.0M
LDOS▼ Sell$1.4M
LDOS▼ Sell$0
LDOS▲ Buy$2.4M
LDOS▼ Sell$4.8M
LDOS▼ Sell$2.5M
LDOS▼ Sell$84K
LDOS▼ Sell$75K
LDOS▼ Sell$37K
LDOS▲ Buy$2.4M
LDOS▼ Sell$4.9M
LDOS▼ Sell$1.3M
LDOS▼ Sell$1.4M
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▲ Buy$2.2M
LDOS▼ Sell$11K
LDOS▼ Sell$4.7M
LDOS▼ Sell$2.7M
LDOS▼ Sell$4.6M
LDOS▲ Buy$2.2M
LDOS▼ Sell$1.2M
LDOS▼ Sell$1.5M
LDOS▼ Sell$205K
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$123K
LDOS▲ Buy$0
LDOS▼ Sell$12K
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▲ Buy$0
LDOS▼ Sell$234K
LDOS▲ Buy$0
LDOS▼ Sell$36K
LDOS▼ Sell$36K
LDOS▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.